Skip to main content

Table 2 Phenotypic resistance patterns amongst clinical BHS isolates (n = 186)

From: Incidence of macrolide–lincosamide–streptogramin B resistance amongst beta-haemolytic streptococci in The Gambia

 

n (%)

Inducible MLSB

5 (2.7%)

Constitutive MLSB

8 (4.3%)

Macrolide resistance only

2 (1.1%)

Clindamycin resistance only

3 (1.6%)

Macrolide–lincosamide susceptible

168 (90.3%)

Total

186 (100%)

  1. MLS B Macrolide–lincosamide–streptogramin B resistance phenotype
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us